Luca Fagnocchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luca Fagnocchi has a total of 285 co-authors. Here are the top co-authors by number of shared publications:
- John Andrew Pospisilik
Van Andel Institute 1 Department of Epigenetics Grand Rapids, Michigan
21 shared publications - Ilaria Panzeri
Van Andel Institute 1 Department of Epigenetics Grand Rapids, Michigan
18 shared publications - Stefanos Apostle
Van Andel Institute 1 Department of Epigenetics Grand Rapids, Michigan
18 shared publications - Zachary Madaj
Van Andel Institute
18 shared publications - Kristin Gallik
Optical Imaging Core Facility, Van Andel Institute, Grand Rapids, MI, USA
16 shared publications - Eric H. Ma
Van Andel Institute 5 Department of Metabolism and Nutritional Programming Grand Rapids, Michigan
15 shared publications
Latest Publications
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Longitudinal body and fat mass measurements, adipose and tissue immune staining, lymphocyte gating strategy, and genotype/diet comparisons across female and male mice under chow or high-fat diet conditions.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Longitudinal body and fat mass measurements, adipose and tissue immune staining, lymphocyte gating strategy, and genotype/diet comparisons across female and male mice under chow or high-fat diet conditions.
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Summary of the thermal cycling parameters, including temperatures and durations for denaturation, annealing, and extension phases, used for the PCR amplification of the Trp53 gene.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Summary of the thermal cycling parameters, including temperatures and durations for denaturation, annealing, and extension phases, used for the PCR amplification of the Trp53 gene.
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Comparison of tumor-free survival and overall survival curves between Trp53(R270H/+) and wild-type mice, stratified by sex and diet, along with quantitative analysis of tumor multiplicity and the distribution of primary versus metastatic lesions.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Comparison of tumor-free survival and overall survival curves between Trp53(R270H/+) and wild-type mice, stratified by sex and diet, along with quantitative analysis of tumor multiplicity and the distribution of primary versus metastatic lesions.
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Comprehensive individual mouse records including genotype, sex, and diet assignments, longitudinal body weight and composition measurements, age at sacrifice, and detailed pathological assessments of tumor incidence and metastatic status.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Comprehensive individual mouse records including genotype, sex, and diet assignments, longitudinal body weight and composition measurements, age at sacrifice, and detailed pathological assessments of tumor incidence and metastatic status.
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Sequences for the forward and reverse primers and allele-specific probes used for the quantitative PCR-based discrimination between wild-type and mutant Trp53 alleles.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Sequences for the forward and reverse primers and allele-specific probes used for the quantitative PCR-based discrimination between wild-type and mutant Trp53 alleles.
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Figure 2 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
HFD does not alter survival, burden, or overall spectrum in Trp53R270H/+ mice. A, Kaplan–Meier survival probability for Trp53R270H/+ animals under CD (beige) or HFD (green) diet. No significant differences were observed with a log-rank test, P = 0.84. N = 155 animals (60 CD vs. 95 HFD, pooled female and male data). B, Cumulative distribution of tumor burden (number of tumors per animal) in Trp53R270H/+ animals fed with CD or HFD. No significant differences (ns) were observed according to an asymptotic two-sided, two-sample Kolmogorov–Smirnov test (D = 0.020408, P value = 1). N = 97 animals (61 HFD vs. 36 CD, pooled female and male data). C, Prevalence of each tumor type over the total number of tumors in CD or HFD-fed Trp53R270H/+ animals. N = 168 tumors (108 tumors in HFD- vs. 60 in CD-fed animals, pooled female and male data). No significant differences (ns) were detected using Poisson regression with a log offset for time until euthanasia. A.R., age-related. D, Kaplan–Meier survival probability for Trp53R270H/+ animals under CD (beige) or HFD (green) diet for the different tumor types, as specified in the y-axis. No significant differences were observed with a log-rank test: P = 0.17 (carcinomas), 0.38 (sarcomas), 0.7 (leukemia), and 0.13 (lymphomas). N = 155 animals (60 CD vs. 95 HFD, pooled female and male data). E, Distribution of primary tumor sites in Trp53R270H/+ mice fed CD or HFD. Bubble size indicates the percentage of animals with tumors in each organ. Poisson regression with a log offset for time until euthanasia. To control the false-positive rate, we considered a tissue significant only if its 95% confidence interval (CI) for the odds ratio lay entirely above 1.1 or entirely below 0.9. For lungs, P = 0.0357328, estimate = 2.1736567, and 95% CI, 0.1449047–4.2024087. ns, nonsignificant. N = 92 animals (21 females and 15 males under CD and 33 females and 23 males under HFD). GEJ, gastroesophageal junction; PNS, peripheral nervous system. *, P < 0.05.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
HFD does not alter survival, burden, or overall spectrum in Trp53R270H/+ mice. A, Kaplan–Meier survival probability for Trp53R270H/+ animals under CD (beige) or HFD (green) diet. No significant differences were observed with a log-rank test, P = 0.84. N = 155 animals (60 CD vs. 95 HFD, pooled female and male data). B, Cumulative distribution of tumor burden (number of tumors per animal) in Trp53R270H/+ animals fed with CD or HFD. No significant differences (ns) were observed according to an asymptotic two-sided, two-sample Kolmogorov–Smirnov test (D = 0.020408, P value = 1). N = 97 animals (61 HFD vs. 36 CD, pooled female and male data). C, Prevalence of each tumor type over the total number of tumors in CD or HFD-fed Trp53R270H/+ animals. N = 168 tumors (108 tumors in HFD- vs. 60 in CD-fed animals, pooled female and male data). No significant differences (ns) were detected using Poisson regression with a log offset for time until euthanasia. A.R., age-related. D, Kaplan–Meier survival probability for Trp53R270H/+ animals under CD (beige) or HFD (green) diet for the different tumor types, as specified in the y-axis. No significant differences were observed with a log-rank test: P = 0.17 (carcinomas), 0.38 (sarcomas), 0.7 (leukemia), and 0.13 (lymphomas). N = 155 animals (60 CD vs. 95 HFD, pooled female and male data). E, Distribution of primary tumor sites in Trp53R270H/+ mice fed CD or HFD. Bubble size indicates the percentage of animals with tumors in each organ. Poisson regression with a log offset for time until euthanasia. To control the false-positive rate, we considered a tissue significant only if its 95% confidence interval (CI) for the odds ratio lay entirely above 1.1 or entirely below 0.9. For lungs, P = 0.0357328, estimate = 2.1736567, and 95% CI, 0.1449047–4.2024087. ns, nonsignificant. N = 92 animals (21 females and 15 males under CD and 33 females and 23 males under HFD). GEJ, gastroesophageal junction; PNS, peripheral nervous system. *, P < 0.05.
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Details of the restriction enzyme digestion protocol, including specific incubation temperatures and times for the MslI enzyme and subsequent heat inactivation, used for Trp53 allele discrimination.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Details of the restriction enzyme digestion protocol, including specific incubation temperatures and times for the MslI enzyme and subsequent heat inactivation, used for Trp53 allele discrimination.
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Detailed comparison of energy distribution, macronutrient mass composition, and micronutrient profiles between the standard Purina 5021 chow and the D12492 high-fat purified diet used in the study.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Detailed comparison of energy distribution, macronutrient mass composition, and micronutrient profiles between the standard Purina 5021 chow and the D12492 high-fat purified diet used in the study.
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Obesity is a complex chronic disease characterized by excessive adiposity and multiple comorbidities, including an elevated risk of several cancers. Despite long-standing epidemiologic links, the causal relationship between body mass index and reduced cancer survival remains controversial, underscoring the need to define how obesity-related factors—such as chronic high-fat diet (HFD) exposure—influence tumor development in the context of defined oncogenic lesions. Here, we report the effects of chronic HFD-induced obesity on cancer progression in Trp53R270H/+ mice, a model of human Li–Fraumeni syndrome characterized by spontaneous multicancer susceptibility. Surprisingly, despite rapid, sustained, and highly penetrant obesity, more than 1 year of HFD had no significant effect on overall survival, tumor burden, or tumor spectrum across more than 20 anatomic sites in Trp53-mutant mice. Crucially, we did identify a single, tissue-specific exception in the lung, with HFD-fed animals showing increased prevalence of lung tumors that correlated with unique, diet-specific changes in Trp53 allelic and protein profiles. Notably, chronic HFD in this model triggered adipose-specific, not systemic, inflammation. These robust findings, replicated independently in two cohorts totaling 359 mice, suggest that Trp53R270H-driven multicancer syndrome is largely refractory to HFD-driven acceleration. Our results provide evidence that chronic diet-induced obesity does not universally enhance tumorigenesis, highlighting the complexity, tissue specificity, and context-dependent nature of obesity–cancer interactions.Significance:Obesity is widely linked to cancer risk, yet causality remains debated. Using large, longitudinal cohorts of Li–Fraumeni Trp53R270H/+ mice, this study shows that chronic HFD-induced obesity does not broadly accelerate tumor burden or shorten survival, revealing strong tissue specificity, with lung cancer as a notable exception.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Obesity is a complex chronic disease characterized by excessive adiposity and multiple comorbidities, including an elevated risk of several cancers. Despite long-standing epidemiologic links, the causal relationship between body mass index and reduced cancer survival remains controversial, underscoring the need to define how obesity-related factors—such as chronic high-fat diet (HFD) exposure—influence tumor development in the context of defined oncogenic lesions. Here, we report the effects of chronic HFD-induced obesity on cancer progression in Trp53R270H/+ mice, a model of human Li–Fraumeni syndrome characterized by spontaneous multicancer susceptibility. Surprisingly, despite rapid, sustained, and highly penetrant obesity, more than 1 year of HFD had no significant effect on overall survival, tumor burden, or tumor spectrum across more than 20 anatomic sites in Trp53-mutant mice. Crucially, we did identify a single, tissue-specific exception in the lung, with HFD-fed animals showing increased prevalence of lung tumors that correlated with unique, diet-specific changes in Trp53 allelic and protein profiles. Notably, chronic HFD in this model triggered adipose-specific, not systemic, inflammation. These robust findings, replicated independently in two cohorts totaling 359 mice, suggest that Trp53R270H-driven multicancer syndrome is largely refractory to HFD-driven acceleration. Our results provide evidence that chronic diet-induced obesity does not universally enhance tumorigenesis, highlighting the complexity, tissue specificity, and context-dependent nature of obesity–cancer interactions.Significance:Obesity is widely linked to cancer risk, yet causality remains debated. Using large, longitudinal cohorts of Li–Fraumeni Trp53R270H/+ mice, this study shows that chronic HFD-induced obesity does not broadly accelerate tumor burden or shorten survival, revealing strong tissue specificity, with lung cancer as a notable exception.
- Open Access
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Nucleotide sequences for the forward and reverse primers used for the PCR-based genotyping of the Trp53 alleles in the experimental mouse cohort.
- 8 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Chronic High-Fat Diet Does Not Alter Overall Cancer Incidence in Trp53R270H/+ Mice
Nucleotide sequences for the forward and reverse primers used for the PCR-based genotyping of the Trp53 alleles in the experimental mouse cohort.